We are live on ! Find out more
ACPU

Arrowgrass Capital Partners (US) Portfolio holdings

AUM $380M
1-Year Est. Return 20.87%
This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+20.87%
3 Year Est. Return
+55.83%
5 Year Est. Return
+146.17%
10 Year Est. Return
AUM
$2.67B
AUM Growth
+$1.69B
Cap. Flow
+$1.21B
Cap. Flow %
45.46%
Top 10 Hldgs %
41.81%
Holding
219
New
110
Increased
30
Reduced
10
Closed
43

Sector Composition

Rank Sector Weight
1 Healthcare 13.1%
2 Energy 6.19%
3 Consumer Discretionary 5.92%
4 Financials 3.84%
5 Technology 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBR icon
76
Nabors Industries
NBR
$1.27B
$5.24M 0.2%
6,520
-540
-8% -$424K
DHR icon
77
Danaher
DHR
$137B
$5.2M 0.19%
+111,587
New +$5.06M
NE
78
DELISTED
Noble Corporation
NE
$5.1M 0.19%
154,440
+12,698
+9% +$432K
EVTC icon
79
Evertec
EVTC
$1.88B
$5M 0.19%
+225,000
New +$5.36M
CIE
80
CALL
DELISTED
Cobalt International Energy, Inc
CIE
$4.97M 0.19%
+13,333
New +$5.39M
XLB icon
81
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$4.87M 0.18%
231,600
LRCX icon
82
Lam Research
LRCX
$367B
$4.83M 0.18%
943,500
+494,500
+110% +$2.42M
NEM icon
83
Newmont
NEM
$98.7B
$4.79M 0.18%
+170,614
New +$5.06M
ZIONW
84
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
$4.75M 0.18%
+964,800
New +$5.85M
XLB icon
85
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$4.68M 0.18%
222,800
BMY icon
86
PUT
Bristol-Myers Squibb
BMY
$133B
$4.63M 0.17%
+100,000
New +$4.39M
TMO icon
87
Thermo Fisher Scientific
TMO
$213B
$4.61M 0.17%
+50,000
New +$4.52M
TLM
88
DELISTED
TALISMAN ENERGY INC
TLM
$4.6M 0.17%
+400,000
New +$4.47M
MSFT icon
89
CALL
Microsoft
MSFT
$3.45T
$4.42M 0.17%
132,700
-549,700
-81% -$18.1M
QCOM icon
90
CALL
Qualcomm
QCOM
$155B
$4.38M 0.16%
+65,000
New +$4.26M
PGEM
91
DELISTED
Ply Gem Holdings, Inc.
PGEM
$4.35M 0.16%
310,939
+238,867
+331% +$4.13M
TIBX
92
DELISTED
TIBCO SOFTWARE INC
TIBX
$4.16M 0.16%
+162,452
New +$3.88M
IDIX
93
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$4.15M 0.16%
+800,400
New +$3.51M
CRZO
94
DELISTED
Carrizo Oil & Gas Inc
CRZO
$4.1M 0.15%
+110,000
New +$3.66M
FDO
95
DELISTED
FAMILY DOLLAR STORES
FDO
$4.09M 0.15%
+56,861
New +$3.99M
EVRY
96
DELISTED
EVERYWARE GLOBAL INC COM STK (DE)
EVRY
$4.01M 0.15%
352,028
+164,348
+88% +$2.07M
ACHN
97
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$3.95M 0.15%
+1,307,900
New +$8.97M
LIND icon
98
Lindblad Expeditions
LIND
$1.94B
$3.89M 0.15%
+401,100
New +$3.91M
BIOA
99
DELISTED
BioAmber Inc.
BIOA
$3.7M 0.14%
755,900
+500
+0.1% +$2.85K
PEP icon
100
PepsiCo
PEP
$190B
$3.7M 0.14%
+46,500
New +$3.82M

Similar funds

Arrowgrass Capital Partners (US)'s Q3 2013 Portfolio in Review

As of Q3 2013, Arrowgrass Capital Partners (US) held 219 positions worth $2.67B, up 173% from $977M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Arrowgrass Capital Partners (US) deployed $1.21B of net new capital in Q3 2013, opening 110 new positions and adding to 30 existing holdings. Its largest new stake was ONYX PHARMACEUTICALS INC: 1,976,636 shares worth $246M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 6.6% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $18.5M trimmed.

  • Arrowgrass Capital Partners (US)'s largest Q3 2013 buy was ONYX PHARMACEUTICALS INC: 1,976,636 shares worth $246M.
  • Arrowgrass Capital Partners (US) added most to ELAN CORP ADS(RP1 ORD4IRISH PN in Q3 2013, an estimated $118M increase.
  • Arrowgrass Capital Partners (US)'s biggest Q3 2013 reduction was Freeport-McMoran, cutting an estimated $18.5M.
  • Arrowgrass Capital Partners (US) fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $82.1M.
  • Arrowgrass Capital Partners (US)'s ten largest holdings make up 42% of its $2.67B portfolio in Q3 2013.
  • Arrowgrass Capital Partners (US) opened 110 new positions and closed 43 in Q3 2013.
  • Arrowgrass Capital Partners (US)'s portfolio value rose 173% quarter-over-quarter to $2.67B.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2013, filed 14 Nov 2013.